Literature DB >> 1661746

Antibodies to seven rotavirus serotypes in cord sera, maternal sera, and colostrum of German women.

H Brüssow1, J Sidoti, L Lerner, H Rahim, W Eckstein, H Werchau, C Mietens.   

Abstract

Forty percent of colostrum samples from German women showed neutralizing antibody titers of greater than or equal to 50 to rotavirus (RV) serotypes 1, 3, 4, and 6. Antibody to serotypes 2, 8, and 9 was less prevalent. Titers are, however, too low to indicate an important effect of colostrum on the RV vaccine take rate. On the other hand, about 50% of the cord serum samples showed high neutralizing-antibody titers to serotypes 1, 3, and 4, which could interfere with the take rate of RV vaccines based on these serotypes in very young infants.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1661746      PMCID： PMC270446          DOI： 10.1128/jcm.29.12.2856-2859.1991

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  21 in total

1.  Difference between bacterial and food antigens in mucosal immunogenicity.

Authors:  A E Wold; U I Dahlgren; L A Hanson; I Mattsby-Baltzer; T Midvetdt
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

2.  Neutralizing antibodies to heterologous animal rotavirus serotypes 5, 6, 7, and 10 in sera from Ecuadorian children.

Authors:  H Brüssow; P A Offit; J Sidoti
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

3.  Rotavirus neutralisation by human milk.

Authors:  M E Thouless; A S Bryden; T H Flewett
Journal:  Br Med J       Date:  1977-11-26

4.  Serotype-specific antibodies to rotavirus in human colostrum and breast milk and in maternal and cord blood.

Authors:  M Ringenbergs; M J Albert; G P Davidson; W Goldworthy; R Haslam
Journal:  J Infect Dis       Date:  1988-08       Impact factor: 5.226

5.  Rotavirus serotype-specific neutralizing activity in human milk.

Authors:  L M Bell; H F Clark; P A Offit; P H Slight; A M Arbeter; S A Plotkin
Journal:  Am J Dis Child       Date:  1988-03

6.  Bovine milk immunoglobulins for passive immunity to infantile rotavirus gastroenteritis.

Authors:  H Brüssow; H Hilpert; I Walther; J Sidoti; C Mietens; P Bachmann
Journal:  J Clin Microbiol       Date:  1987-06       Impact factor: 5.948

7.  Protective effect of WC3 vaccine against rotavirus diarrhea in infants during a predominantly serotype 1 rotavirus season.

Authors:  H F Clark; F E Borian; L M Bell; K Modesto; V Gouvea; S A Plotkin
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

8.  Reactions to and antigenicity of two human-rhesus rotavirus reassortant vaccine candidates of serotypes 1 and 2 in Venezuelan infants.

Authors:  J Flores; I Perez-Schael; M Blanco; M Vilar; D Garcia; M Perez; N Daoud; K Midthun; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

Review 9.  Prospects for development of a rotavirus vaccine against rotavirus diarrhea in infants and young children.

Authors:  A Z Kapikian; J Flores; Y Hoshino; K Midthun; M Gorziglia; K Y Green; R M Chanock; L Potash; S D Sears; M L Clements
Journal:  Rev Infect Dis       Date:  1989 May-Jun

10.  Rotavirus antibodies in the mother and her breast-fed infant.

Authors:  K Hjelt; P C Grauballe; O H Nielsen; P O Schiøtz; P A Krasilnikoff
Journal:  J Pediatr Gastroenterol Nutr       Date:  1985-06       Impact factor: 2.839
View more
  3 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

2.  Effect of malnutrition on serum and milk antibodies in Zairian women.

Authors:  H Brüssow; D Barclay; J Sidoti; S Rey; A Blondel; H Dirren; A M Verwilghen; C Van Geert
Journal:  Clin Diagn Lab Immunol       Date:  1996-01

3.  Rotavirus-inhibitory activity in serial milk samples from Mexican women and rotavirus infections in their children during their first year of life.

Authors:  H Brüssow; O Benitez; F Uribe; J Sidoti; K Rosa; A Cravioto
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.